Disruption of NCOA2 by Recurrent Fusion with LACTB2 in Colorectal Cancer

Overview

Journal Oncogene

Specialties Molecular Biology
Oncology

Date 2015 Mar 31

PMID 25823027

Citations 18

Authors

J Yu

W K K Wu

Q Liang

N Zhang

J He

X Li

X Zhang

L Xu

M T V Chan

S S M Ng

J J Y Sung

Affiliations

Soon will be listed here.

Abstract

Whole-genome and transcriptome sequencing were used to discover novel gene fusions in a case of colon cancer. A tumor-specific LACTB2-NCOA2 fusion originating from intra-chromosomal rearrangement of chromosome 8 was identified at both DNA and RNA levels. Unlike conventional oncogenic chimeric proteins, the fusion product lacks functional domain from respective genes, indicative of an amorphic rearrangement. This chimeric LACTB2-NCOA2 transcript was detected in 6 out of 99 (6.1%) colorectal cancer (CRC) cases, where NCOA2 was significantly downregulated. Enforced expression of wild-type NCOA2 but not the LACTB2-NCOA2 fusion protein impaired the pro-tumorigenic phenotypes of CRC cells, whereas knockdown of endogenous NCOA2 in normal colonocytes had opposite effects. Mechanistically, NCOA2 inhibited Wnt/β-catenin signaling through simultaneously upregulating inhibitors and downregulating stimulators of Wnt/β-catenin pathway. Collectively, our data supports that NCOA2 is a novel negative growth regulatory gene repressing the Wnt/β-catenin pathway in CRC, where recurrent fusion with LACTB2 contributes to its disruption.

Citing Articles

VGLL2 and TEAD1 fusion proteins drive YAP/TAZ-independent tumorigenesis by engaging p300.

Guo S, Hu X, Cotton J, Ma L, Li Q, Cui J bioRxiv. 2024; .

PMID: 38746415 PMC: 11092657. DOI: 10.1101/2024.05.01.592016.

p160 nuclear receptor coactivator family members and their role in rare fusion‑driven neoplasms (Review).

Segovia D, Safaric Tepes P Oncol Lett. 2024; 27(5):210.

PMID: 38572059 PMC: 10988192. DOI: 10.3892/ol.2024.14343.

Identification of the prognostic value of LACTB2 and its correlation with immune infiltrates in ovarian cancer by integrated bioinformatics analyses.

Cao W, Wang C, Zhang Y, Yang J, Luo X, Zhao Y Eur J Med Res. 2024; 29(1):166.

PMID: 38475882 PMC: 10929091. DOI: 10.1186/s40001-024-01762-2.

Epigenetic differences in NCOA2: a novel biomarker that predicts prognosis in clear cell renal cell carcinoma.

Chen Z, Wang L, Shi J, Xiao W, Yuan C, Meng X Am J Transl Res. 2023; 15(4):2515-2527.

PMID: 37193192 PMC: 10182516.

Network Pharmacology-Based Analysis of the Potential Biological Mechanisms of Coix Seed against Colorectal Cancer.

Sun Y, Jiang P, Yang H, Zhang Z, Zhou Y, Li P Evid Based Complement Alternat Med. 2022; 2022:9261768.

PMID: 36248436 PMC: 9560812. DOI: 10.1155/2022/9261768.

References

Liang J, PROUTY L, Williams B, Dayton M, Blanchard K . Acute mixed lineage leukemia with an inv(8)(p11q13) resulting in fusion of the genes for MOZ and TIF2. Blood. 1998; 92(6):2118-22. View

Yoshida H, Miyachi M, Sakamoto K, Ouchi K, Yagyu S, Kikuchi K . PAX3-NCOA2 fusion gene has a dual role in promoting the proliferation and inhibiting the myogenic differentiation of rhabdomyosarcoma cells. Oncogene. 2013; 33(49):5601-8. DOI: 10.1038/onc.2013.491. View

Kefalopoulou Z, Tzelepi V, Zolota V, Grivas P, Christopoulos C, Kalofonos H . Prognostic value of novel biomarkers in astrocytic brain tumors: nuclear receptor co-regulators AIB1, TIF2, and PELP1 are associated with high tumor grade and worse patient prognosis. J Neurooncol. 2011; 106(1):23-31. DOI: 10.1007/s11060-011-0637-y. View

Aguilera O, Pena C, Garcia J, Larriba M, Ordonez-Moran P, Navarro D . The Wnt antagonist DICKKOPF-1 gene is induced by 1alpha,25-dihydroxyvitamin D3 associated to the differentiation of human colon cancer cells. Carcinogenesis. 2007; 28(9):1877-84. DOI: 10.1093/carcin/bgm094. View

Yu J, Wu W, Li X, He J, Li X, Ng S . Novel recurrently mutated genes and a prognostic mutation signature in colorectal cancer. Gut. 2014; 64(4):636-45. PMC: 4392212. DOI: 10.1136/gutjnl-2013-306620. View

Xi Y, Formentini A, Chien M, Weir D, Russo J, Ju J . Prognostic Values of microRNAs in Colorectal Cancer. Biomark Insights. 2007; 2:113-121. PMC: 2134920. View

Walfish P, Yoganathan T, Yang Y, Hong H, Butt T, Stallcup M . Yeast hormone response element assays detect and characterize GRIP1 coactivator-dependent activation of transcription by thyroid and retinoid nuclear receptors. Proc Natl Acad Sci U S A. 1997; 94(8):3697-702. PMC: 20503. DOI: 10.1073/pnas.94.8.3697. View

Wu J, Ji X, Zhu L, Jiang Q, Wen Z, Xu S . Up-regulation of microRNA-1290 impairs cytokinesis and affects the reprogramming of colon cancer cells. Cancer Lett. 2012; 329(2):155-63. DOI: 10.1016/j.canlet.2012.10.038. View

Quintas-Cardama A, Cortes J . Molecular biology of bcr-abl1-positive chronic myeloid leukemia. Blood. 2008; 113(8):1619-30. PMC: 3952549. DOI: 10.1182/blood-2008-03-144790. View

10.

Frenkel-Morgenstern M, Lacroix V, Ezkurdia I, Levin Y, Gabashvili A, Prilusky J . Chimeras taking shape: potential functions of proteins encoded by chimeric RNA transcripts. Genome Res. 2012; 22(7):1231-42. PMC: 3396365. DOI: 10.1101/gr.130062.111. View

11.

Arbajian E, Magnusson L, Mertens F, Domanski H, Vult von Steyern F, Nord K . A novel GTF2I/NCOA2 fusion gene emphasizes the role of NCOA2 in soft tissue angiofibroma development. Genes Chromosomes Cancer. 2012; 52(3):330-1. DOI: 10.1002/gcc.22033. View

12.

Guo G, Sun X, Chen C, Wu S, Huang P, Li Z . Whole-genome and whole-exome sequencing of bladder cancer identifies frequent alterations in genes involved in sister chromatid cohesion and segregation. Nat Genet. 2013; 45(12):1459-63. PMC: 7512009. DOI: 10.1038/ng.2798. View

13.

DErrico I, Moschetta A . Nuclear receptors, intestinal architecture and colon cancer: an intriguing link. Cell Mol Life Sci. 2008; 65(10):1523-43. PMC: 11131893. DOI: 10.1007/s00018-008-7552-1. View

14.

Akiva P, Toporik A, Edelheit S, Peretz Y, Diber A, Shemesh R . Transcription-mediated gene fusion in the human genome. Genome Res. 2005; 16(1):30-6. PMC: 1356126. DOI: 10.1101/gr.4137606. View

15.

Herai R, Yamagishi M . Detection of human interchromosomal trans-splicing in sequence databanks. Brief Bioinform. 2009; 11(2):198-209. DOI: 10.1093/bib/bbp041. View

16.

Maher C, Palanisamy N, Brenner J, Cao X, Kalyana-Sundaram S, Luo S . Chimeric transcript discovery by paired-end transcriptome sequencing. Proc Natl Acad Sci U S A. 2009; 106(30):12353-8. PMC: 2708976. DOI: 10.1073/pnas.0904720106. View

17.

Malkova A, Ira G . Break-induced replication: functions and molecular mechanism. Curr Opin Genet Dev. 2013; 23(3):271-9. PMC: 3915057. DOI: 10.1016/j.gde.2013.05.007. View

18.

Hong H, Kohli K, Trivedi A, Johnson D, Stallcup M . GRIP1, a novel mouse protein that serves as a transcriptional coactivator in yeast for the hormone binding domains of steroid receptors. Proc Natl Acad Sci U S A. 1996; 93(10):4948-52. PMC: 39385. DOI: 10.1073/pnas.93.10.4948. View

19.

Bass A, Lawrence M, Brace L, Ramos A, Drier Y, Cibulskis K . Genomic sequencing of colorectal adenocarcinomas identifies a recurrent VTI1A-TCF7L2 fusion. Nat Genet. 2011; 43(10):964-968. PMC: 3802528. DOI: 10.1038/ng.936. View

20.

Wong S, Sung J, Chan F, To K, Ng S, Wang X . Genome-wide association and sequencing studies on colorectal cancer. Semin Cancer Biol. 2013; 23(6 Pt B):502-11. DOI: 10.1016/j.semcancer.2013.09.005. View